Progentos Therapeutics

Pheno Therapeutics

This biotech company develops neuroprotective and remyelinating therapies for patients with multiple sclerosis and other neurodegenerative disorders.

Convelo Therapeutics

This biotechnology company develops medicines to regenerate nerve cell myelin for patients with neurological disorders, including multiple sclerosis and paediatric leukodystrophies.

Accure Therapeutics

This biopharmaceutical company develops central nervous system medicines to treat patients with conditions such as multiple sclerosis, Parkinson's disease, epilepsy and optic neuritis.

Disarm Therapeutics

This biotechnology firm develops small-molecule SARM1 inhibitors to prevent axonal degeneration for patients with neurological conditions like multiple sclerosis and amyotrophic lateral sclerosis.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Autobahn Therapeutics

This company develops brain-penetrating small molecule therapies for patients with neuropsychiatric and neuroimmunologic disorders, including depression and multiple sclerosis.

Contineum Therapeutics

This company develops oral small-molecule therapies for patients with inflammatory, fibrotic and neurological diseases, including idiopathic pulmonary fibrosis and progressive multiple sclerosis.

Cadenza Bio

This biotechnology company develops small-molecule drugs to treat demyelinating and inflammatory diseases, such as multiple sclerosis and endometriosis, for patients and healthcare providers.